The effects of adjuvant honey
therapy on disease activity,
lymphocyte function and
lymphocyte subsets in patients with systemic lupus erythematosus (SLE)

QR Code

The effects of adjuvant honey therapy on disease activity, lymphocyte function and lymphocyte subsets in patients with systemic lupus erythematosus (SLE)

Objectives: To compare the effects of adjuvant tualang honey therapy versus conventional therapy alone on disease activity, lymphocyte functions and lymphocyte subsets in SLE patients. Methodology: Sixty SLE patients from Hospital Universiti Sains Malaysia were randomized into two equal groups, g...

Full description

Bibliographic Details
Main Author:	Daud, Kamaliah Mohd
Format:	Monograph
Language:	English
Published:	Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia 2010
Subjects:	R Medicine
Online Access:	http://eprints.usm.my/54529/ http://eprints.usm.my/54529/1/Kamaliah%20Mohd%20Daud-Eprints.pdf

Similar Items

Effects Of Adjuvant Honey Therapy On Disease Activity, Lymphocyte Function And Lymphocyte Subsets In Patients With Systemic Lupus Erythematosus
by: Mohamad, Wathik M.
Published: (2009)

Contribution of increased apoptosis in monocytes and lymphocytes in the etiopathogenesis of systemic lupus erythematosus (SLE)
by: Che Maraina, Che Hussin
Published: (2012)

A study of lymphocyte subsets, activation markers and herpers viruses infection in epileptic patients in HUSM
by: Ab. Hamid, Wan Zuraida Wan
Published: (2011)

A study of lymphocyte subsets, activation markers and herpers viruses infection in epileptic patients in HUSM
by: Hamid, Wan Zuraida Wan Ab., et al.
Published: (2011)

The relationship between a state of mindfulness and hardiness with emotional distress and suicidal ideation in patients with Systemic Lupus Erythematosus (SLE)
by: Azman, Nur Aishah, et al.
Published: (2019)

A-15-year experience of paediatric systemic lupus erythematosus (pSLE) in Hospital Universiti Sains Malaysia
by: Allamani Alin, Jamil Mohammed
Published: (2014)

Gender balance in patients with systemic lupus erythematosus
by: Margery-Muir, A., et al.
Published: (2016)

Drugs for discoid lupus erythematosus
by: Jessop, Sue, et al.
Published: (2017)

Anti-nucleosome antibodies as a disease activity marker in patients with systematic lupus erythematosus
by: Ha, Suliman Tayseer
Published: (2006)

Vitamin D levels and steroid usage are not associated with disease activity in systemic lupus erythematosus patients
by: Ibrahim, Izzaidah, et al.
Published: (2022)

Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families
by: Kuo, Chang-Fu, et al.
Published: (2015)

Occurrence of primary lymphocytic hypophysitis in two horses and presence of scattered T-lymphocytes in the normal equine pituitary gland
by: Grau-Roma, Llorenc, et al.
Published: (2017)

Determination of lymphocyte subjects in patients with major depressive disorder (MDD)
by: Sanusi, Siti Nor Fairus Mohamed
Published: (2018)

Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia
by: Ghassemifar, Reza, et al.
Published: (2012)

Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients
by: CS, Syahidatulamali, et al.
Published: (2017)

CD3CD4gp130 T cells are associated with worse disease activity in systemic lupus erythematosus patients
by: Mohd Shukri, Nur Diyana, et al.
Published: (2021)

CD3+CD4+gp130+ T cells are associated with worse disease activity in systemic Lupus Erythematosus patients
by: Mohd Shukri, Nur Diyana, et al.
Published: (2021)

Aktiviti Bakterisidal in vitro Fagosit daripada Pesakit Lupus Eritematosus Sistemik (SLE)
by: Musa, M, et al.
Published: (1989)

Cytogenomic profiling of chronic lymphocytic leukaemia patients using dna microarray
by: Zamri, Wan Norizzati Wan Mohamad
Published: (2021)

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
by: Rees, Frances, et al.
Published: (2014)

Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012
by: Rees, Frances, et al.
Published: (2016)

Burden of comorbidity in systemic lupus erythematosus in the UK, 1999–2012
by: Rees, Frances, et al.
Published: (2016)

Rare presentation of systemic lupus erythematosus with idiopathic intracranial hypertension
by: Ang, Diana Lee Min, et al.
Published: (2018)

Predictive factors and renal outcomes in childhood systemic lupus erythematosus
by: Zawavi, Mohd Haikal Abdullah
Published: (2023)

Indirect immunofluorescence screening of potential arthritic autoantibodies in systemic lupus erythematosus
by: Selvaraja, Malarvili, et al.
Published: (2018)

Serum th1 and th2 cytokines in systemic lupus erythematosus patients : its relationship with disease activity and organ involvement
by: Kanowah, Eshan
Published: (2006)

Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: Case series from a single institution
by: Wan, S. A., et al.
Published: (2016)

Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis
by: Selvaraja, Malarvili, et al.
Published: (2019)

Immune markers and human leukocyte antigen polymorphisms associated with disease severity in systemic lupus erythematosus
by: Selvaraja, Malarvili
Published: (2019)

Elucidation of serum levels of IL-17, IL-23 and their receptors in systemic lupus erythematosus patients : associations with serological parameter and disease activity
by: Aziz, Farah Izati
Published: (2020)

Elucidation of serum interleukin-35 levels and interleukin-35 receptors in systemic lupus erythematosus patients: association with serological parameters and disease activity
by: Shukri, Nur Diyana Mohd
Published: (2021)

Inhibitory effect of mesenchymal stem cells on lymphocyte proliferation.
by: Gao, K., et al.
Published: (2008)

Characterisation on the role of non B lymphocytes during infectious bursal disease virus infection.
by: Omar, Abdul Rahman, et al.

Effect of calcitriol and calcium supplementation in the prevention of glucocorticoid -induced osteoporosis among systemic lupus erythematosus patients
by: Chan, Lee Chin
Published: (2001)

Newly diagnosed systemic lupus erythematosus in a COVID-19 positive patient: a case report
by: Abdul Rahman, Nurul Aimi, et al.
Published: (2022)

Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different
by: Selvaraja, Malarvili, et al.
Published: (2022)

Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)

HLA-DRB1*04 as a risk allele to systemic Lupus Erythematosus and Lupus Nephritis in the Malay population of Malaysia
by: Selvaraja, Malarvili, et al.
Published: (2021)

IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation
by: Penha, Rafael, et al.
Published: (2016)

Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) – masquerade diagnosis: a case report
by: Mohd Hanafi, Mohd Sharil Iman, et al.
Published: (2019)